AP9901724A0 - Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients. - Google Patents

Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients.

Info

Publication number
AP9901724A0
AP9901724A0 APAP/P/1999/001724A AP9901724A AP9901724A0 AP 9901724 A0 AP9901724 A0 AP 9901724A0 AP 9901724 A AP9901724 A AP 9901724A AP 9901724 A0 AP9901724 A0 AP 9901724A0
Authority
AP
ARIPO
Prior art keywords
infective
composition
infective agents
agents
micro
Prior art date
Application number
APAP/P/1999/001724A
Other languages
English (en)
Inventor
Harjinder Singh Bansal
Bakulesh Mafatlal Khamar
Original Assignee
Cadila Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806489.2A external-priority patent/GB9806489D0/en
Application filed by Cadila Pharm Ltd filed Critical Cadila Pharm Ltd
Publication of AP9901724A0 publication Critical patent/AP9901724A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1999/001724A 1998-03-27 1998-04-03 Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients. AP9901724A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9806489.2A GB9806489D0 (en) 1998-03-27 1998-03-27 The process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent/agents and micro organisms as active ingredients
LK1644598 1998-03-27
PCT/IB1998/000445 WO1999049875A1 (en) 1998-03-27 1998-04-03 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients

Publications (1)

Publication Number Publication Date
AP9901724A0 true AP9901724A0 (en) 1999-12-31

Family

ID=26313367

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1999/001724A AP9901724A0 (en) 1998-03-27 1998-04-03 Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients.

Country Status (9)

Country Link
EP (1) EP0998295A1 (uk)
JP (1) JP2002516616A (uk)
AP (1) AP9901724A0 (uk)
AU (1) AU770024B2 (uk)
CA (1) CA2291780A1 (uk)
EA (1) EA002148B1 (uk)
ID (1) ID26341A (uk)
UA (1) UA59394C2 (uk)
WO (1) WO1999049875A1 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227235B2 (en) * 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
US20130131033A1 (en) * 2010-01-13 2013-05-23 Toyochem Laboratories Pharmaceutical composition for treatment of respiratory tract infections
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EA202192193A1 (ru) 2019-02-13 2021-11-09 Итерум Терапьютикс Интернэшнл Лимитед Комбинации бета-лактамных соединений и пробенецида и их применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703360L (sv) * 1987-08-31 1989-03-01 Lejus Medical Ab Granulaera produkter (iii)

Also Published As

Publication number Publication date
JP2002516616A (ja) 2002-06-04
EA199900938A1 (ru) 2000-08-28
AU770024B2 (en) 2004-02-12
CA2291780A1 (en) 1999-10-07
EA002148B1 (ru) 2001-12-24
ID26341A (id) 2000-12-14
AU6415698A (en) 1999-10-18
EP0998295A1 (en) 2000-05-10
WO1999049875A1 (en) 1999-10-07
UA59394C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
HK12495A (en) Pharmaceutical formulations
ATE222495T1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP1243267A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
HUP0000575A2 (hu) Hatóanyagként budesonidot tartalmazó új gyógyszerforma
HUP9901437A2 (hu) Gyógyszerkészítmény, mely amoxicillint és klavulánsavat tartalmaz
FR2613619B1 (fr) Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
RO116343B1 (ro) Compoziţie farmaceutică şi metodă de tratament a infecţiilor bacteriene la pacienţi pediatrici
CA2282082A1 (fr) Microgranules contenant du cisplatine
HUP0001084A2 (hu) 5-ASA-t tartalmazó, módosított hatóanyag-felszabadulást biztosító orális gyógyászati készítmény bélbetegségek kezelésére
AP9901724A0 (en) Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients.
EP0446069A1 (en) Treatment of Clostridium difficile diarrhoea and pseudomembranous colitis
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
US3144387A (en) Anti-inflammatory compositions
ATE150004T1 (de) Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
GB2323532B (en) Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
EP1166800B1 (en) Pharmaceutical compositions containing antibiotics and fructan mixtures
HUP9900521A2 (hu) Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
‘Lon’Jones The next step in infectious disease: taming bacteria
GB950162A (en) Medicines for the treatment of hepatic disorders
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine